Live Breaking News & Updates on Thomas Slavin

Stay updated with breaking news from Thomas slavin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , Nathan Smith , Mychoice Cdx , Thomas Slavin , Megan Manzari , Bracanalysis Cdx , Nicole Lambert , Exchange Commission On , Astrazeneca Ab Corporation , Drug Administration , Us National Cancer Institute , World Most Innovative Companies , Frontier Science Technology Research Foundation , Genetics Inc , Breast International Group , Merck Co Inc , Fast Company , Myriad Genetics , Frontier Science , Technology Research Foundation , Cancer Institute , Uncertain Significance , Most Innovative Companies , Myrisk Hereditary Cancer , Health Illuminated , Private Securities Litigation Reform Act ,

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast. ....

United States , Nathan Smith , Mychoice Cdx , Thomas Slavin , Megan Manzari , Bracanalysis Cdx , Nicole Lambert , Exchange Commission On , Astrazeneca Ab Corporation , Drug Administration , Us National Cancer Institute , World Most Innovative Companies , Frontier Science Technology Research Foundation , Genetics Inc , Breast International Group , Merck Co Inc , Fast Company , Myriad Genetics , Frontier Science , Technology Research Foundation , Cancer Institute , Uncertain Significance , Most Innovative Companies , Myrisk Hereditary Cancer , Health Illuminated , Private Securities Litigation Reform Act ,

New test makes assessing breast cancer risk more precise, equitable for all women, researchers say

New test makes assessing breast cancer risk more precise, equitable for all women, researchers say
ksl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ksl.com Daily Mail and Mail on Sunday newspapers.

United States , Heather Simonsen , Thomas Slavin , Nicole Lambert , Myrisk Hereditary Cancer , Myriad Genetics ,

ACIP readies Friday meeting on vaccine safety, boosters

ACIP readies Friday meeting on vaccine safety, boosters
politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.

New Jersey , United States , Chuck Schumer , Curevac Covid , Donald Trump , Julie Khani , David Lim , Harry Johns , Susannah Luthi , Sam Sutton , Ben Leonard , Paul Offit , Xavier Becerra , Mari Eccles , Caitlin Oprysko , John Yarmuthd Ky , Marina Adami , Chuck Grassleyr Iowa , Michael Carome , Janet Woodcock , Alice Miranda Ollstein , Billy Dunn , Alex Wickham , Emily Martin , Katherine Ellen Foley , Thomas Slavin ,

Myriad Genetics to Share New Data at 2021 ASCO Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries

Share:
SALT LAKE CITY, May 19, 2021 (GLOBE NEWSWIRE) Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced that it will present results from a study with more than 275,000 women validating the use of a new method for polygenic breast cancer risk assessments in women of all ancestries. The new data will be shared in an oral presentation with leading collaborators on June 4 at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting.
The polygenic risk score (PRS) is one of the most powerful risk prediction tools in the field of breast cancer, and until now a validated model had not been available to assess women of all ancestries, said Holly Pederson, M.D., director of Medical Breast Services at Cleveland Clinic and presenter of the study. Our data now provide a framework for a PRS that delivers a personalized genomic breast cancer risk assessment to any and all interested women. The updated PRS, validate ....

United States , Nathan Smith , Jared Maxwell , Thomas Slavin , Bracanalysis Cdx , Nicole Lambert , Holly Pederson , Breast Services At Cleveland Clinic , American Society Of Clinical Oncology , Exchange Commission On , Genetics Inc , Affairs For Oncology At Myriad Genetics , American Cancer Society , Clinical Oncology , Medical Breast Services , Cleveland Clinic , Hereditary Cancer , Myriad Genetic , Medical Affairs , Myriad Genetics , Risk Hereditary Cancer , Risk Hereditary , Private Securities Litigation Reform Act , Transition Report , Exchange Commission , Quarterly Reports ,